Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma

NCT00016263 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: oblimersen sodium
DRUG: dacarbazine

Sponsor

Genta Incorporated